215 related articles for article (PubMed ID: 30043639)
1. FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Albayrak G; Konac E; Ugras Dikmen A; Bilen CY
Exp Biol Med (Maywood); 2018 Aug; 243(12):990-994. PubMed ID: 30043639
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
[TBL] [Abstract][Full Text] [Related]
3. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
4. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
5. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
6. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
7. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.
Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T
PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells.
Li S; Garay JP; Tubbs CA; Franco HL
FEBS Open Bio; 2021 Jun; 11(6):1537-1551. PubMed ID: 33666335
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
10. Influence of hexabromocyclododecane and 4-nonylphenol on the regulation of cell growth, apoptosis and migration in prostatic cancer cells.
Kim SH; Nam KH; Hwang KA; Choi KC
Toxicol In Vitro; 2016 Apr; 32():240-7. PubMed ID: 26804032
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
[TBL] [Abstract][Full Text] [Related]
12. Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.
Albayrak G; Konac E; Dikmen AU; Bilen CY
Hum Exp Toxicol; 2018 Sep; 37(9):953-958. PubMed ID: 29226720
[TBL] [Abstract][Full Text] [Related]
13. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
[TBL] [Abstract][Full Text] [Related]
14. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
15. FOXA1 defines cancer cell specificity.
Zhang G; Zhao Y; Liu Y; Kao LP; Wang X; Skerry B; Li Z
Sci Adv; 2016 Mar; 2(3):e1501473. PubMed ID: 27034986
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.
Lin J; Zhou J; Zhong X; Hong Z; Peng J
Mol Med Rep; 2015 Mar; 11(3):2207-14. PubMed ID: 25394909
[TBL] [Abstract][Full Text] [Related]
17. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
Srivastava SK; Bhardwaj A; Singh S; Arora S; McClellan S; Grizzle WE; Reed E; Singh AP
Carcinogenesis; 2012 Jun; 33(6):1149-57. PubMed ID: 22431717
[TBL] [Abstract][Full Text] [Related]
18. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
19. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
20. Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression.
Xu B; Song B; Lu X; Kim J; Hu M; Zhao JC; Yu J
Cell Res; 2019 Sep; 29(9):773-775. PubMed ID: 31324884
[No Abstract] [Full Text] [Related]
[Next] [New Search]